expenses (4.51) (59.97) (5.21) (2,480.95) Financial cost (0.03) (0.40) (0.06) (28.57) Share of loss in associates (15.06) (200.27) (11.71) (5,576.19) Total expenses (32.57) (433.11) (33.99) (16,185.71
impairment of investments in associate (0.01) (0.05) (1.64) (268.85) Management benefit expenses (11.30) (58.89) (14.16) (2,321.31) Financial cost (0.12) (0.63) (0.14) (22.95) Share of loss in associates
Difference Percentage associate Management benefit expenses (3.73) (4.51) (078) (82.71) Financial cost (0.31) (0.03) (0.28) (1033.33) Share of loss in associates - (15.06) - - Total expenses (16.97) (32.57
benefit expenses (4.72) (4.17) (0.55) (113.19) Financial cost (0.32) (0.04) (0.28) (800.00) Share of loss in associates - (12.84) (12.84) - Total expenses (19.16) (91.05) (71.89) (21.04) Profit (Loss
Type of securities : Common share | Effective Date : 10/06/2023 | Close Selling Date : 16/08/2023
Common share | Initial Public Offering | Offering Date - 07/09/2012 - 11/09/2012